Low-density lipoproteins impair migration of human coronary vascular smooth muscle cells and induce changes in the proteomic profile of myosin light chain

Cardiovascular Research

Volumn 77, Issue 1, 2008, Pages 211-220

  Padró, Teresa ^a   Peña, Esther ^a   García Arguinzonis, Maisa ^a   Llorente Cortes, Vicenta ^a   Badimon, Lina ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Lipoproteins; Migration; Myosin; Proteomics; Smooth muscle cell

Indexed keywords

CYTOSKELETON PROTEIN; LOW DENSITY LIPOPROTEIN; MYOSIN LIGHT CHAIN;

ARTICLE; CELL FUNCTION; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY BLOOD VESSEL; ENZYME INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEOMICS; VASCULAR SMOOTH MUSCLE; VASCULAR SURGERY; WOUND HEALING;

CELL MOVEMENT; CELLS, CULTURED; CORONARY VESSELS; CYTOSKELETAL PROTEINS; HUMANS; LIPOPROTEINS, LDL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHORYLATION; PROTEOMICS; WOUND HEALING;

EID: 38849157043     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvm045     Document Type: Article

References (38)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary disease and the acute coronary syndromes (part I). N Engl J Med 1992;326:242-250.
2. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Rosenfeld ME et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis. Arterioscler Thromb 1994;14:840-856.
3. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994;23:1562-1569.
4. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104:365-372.
5. Rius J, Martinez-Gonzalez J, Crespo J, Badimon L. Involvement of neuron-derived orphan receptor-1 (NOR-1) in LDL-induced mitogenic stimulus in vascular smooth muscle cells: role of CREB. Arterioscler Thromb Vasc Biol 2004;24:697-702.
6. Rodriguez C, Raposo B, Martinez-Gonzalez J, Llorente-Cortes V, Vilahur G, Badimon L. Modulation of ERG25 expression by LDL in vascular cells. Cardiovasc Res 2003;58:178-185.
7. Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G. Association of apoB lipoprotein with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 1998;139:205-222.
8. Williams KJ. Arterial wall chondroitin sulfate proteoglycans: diverse molecules with distinct roles in lipoprotein retention and atherogenesis. Curr Opin Lipidol 2001;12:477-487.
9. Llorente-Cortes V, Martínez-González J, Badimon L. LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000;20:1572- 1579.
10. Llorente-Cortes V, Otero-Viñas M, Badimon L. Differential role of heparan sulfate proteoglycans on aggregated LDL uptake in human vascular smooth muscle cells and mouse embryonic fibroblasts. Arterioscler Thromb Vasc Biol 2002;22:1905-1911.
11. Theilmeier G, Quarck R, Verhamme P, Bochaton-Piallat ML, Lox M et al. Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty. Cardiovasc Res 2002;55:385-395.
12. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996;84:359-369.
13. Zerbinatti CV, Gore RW. Uptake of modified low-density lipoproteins alters actin distribution and locomotor forces in macrophages. Am J Physiol Cell Physiol 2003;284:C555-C561.
14. Martínez-Gonzalez J, Viñals M, Vidal F, Llorente- Cortés V, Badimon L. Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells. Atherosclerosis 1997;135:213-223.
15. Llorente-Cortes V, Martinez-Gonzalez J, Badimon L. Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors. Arterioscler Thromb Vasc Biol 1998;18:738-746.
16. Llorente-Cortes V, Otero-Viñas M, Sanchez S, Rodriguez C, Badimon L. Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism. Circulation 2002;106:3104-3110.
17. Faure P, Oziol L, Le Bihan ML, Chomard P. Cell culture media are potent antioxidants that interfere during LDL oxidation experiments. Biochimie 2004;86:373-378.
18. Dugas TR, Morel DW, Harrison EH. Novel cell culture medium for use in oxidation experiments provides insights into mechanisms of endothelial cell-mediated oxidation of LDL. In Vitro Cell Dev Biol Anim 2000;36:571-577.
19. Llorente-Cortes V, Otero-Viñas M, Hurt-Camejo E, Martínez-González J, Badimon L. Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors. Arterioscler Thromb Vasc Biol 2002;3:87-93.
20. Molloy MP, Herbert BR, Walsh BJ, Tyler MI, Traini M, Sanchez JC et al. Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis 1998;19:837-844.
21. Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, Mische SM. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 1990;20:601-605.
22. Perrie WT, Perry SV. An electrophoretic study of the low-molecular-weight components of myosin. Biochem J 1970;119:31-38.
23. Llorente-Cortes V, Otero-Viñas M, Berrozpe M, Badimon L. Intracellular lipid accumulation, low-density lipoprotein receptor-related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronaries. Eur J Clin Invest 2004;34:182-190.
24. Bogatcheva NV, Verin AD, Wang P, Birukova AA, Birukov KG, Mirzopoyazova T et al. Phorbol esters increase MLC phosphorylation and actin remodeling in bovine lung endothelium without increased contraction. Am J Physiol Lung Cell Mol Physiol 2003;285:L415-L426.
25. Szaszi K, Kurashima K, Kapus A, Paulsen A, Kaibuchi K, Grinstein S et al. RhoA and rho kinase regulate the epithelial Na+/H+ exchanger NHE3. Role of myosin light chain phosphorylation. J Biol Chem 2000;275:28599- 28606.
26. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle nonmuscle myosin II: modulated by G proteins kinases myosin phosphatase. Physiol Rev 2003;83:1325-1358.
27. Williams KJ, Tabas I. The response-to-retention hypothesis of atherogenesis reinforced. Curr Opin Lipidol 1998;9:471-474.
28. Uchimura T, Fumoto K, Yamamoto Y, Ueda K, Hosoya H. Spatial localization of mono-and diphosphorylated myosin II regulatory light chain at the leading edge of motile HeLa cells. Cell Struct Funct 2002;27:479-486.
29. Ai S, Kuzuya M, Koike T, Asai T, Kanda S, Maeda K et al. Rho-Rho kinase is involved in smooth muscle cell migration through myosin light chain phosphorylation-dependent and -independent pathways. Atherosclerosis 2001;155:321-327.
30. Kishi H, Mikawa T, Seto M, Sasaki Y, Kanayasu-Toyoda T, Yamaguchi Tet al. Stable transfectants of smooth muscle cell line lacking the expression of myosin light chain kinase and their characterization with respect to the actomyosin system. J Biol Chem 2000;275:1414-1420.
31. Xia D, Stull JT, Kamm KE. Myosin phosphatase targeting subunit 1 affects cell migration by regulating myosin phosphorylation and actin assembly. Exp Cell Res 2005;304:506-517.
32. Graf K, Xi XP, Yang D, Fleck E, Hsueh WA, Law RE. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension 1997;29:334-339.
33. Otero-Vinas M, Llorente-Cortes V, Pena E, Padró T, Badimon L. Aggregated low density lipoproteins decrease metalloproteinase-9 expression and activity in human coronary smooth muscle cells. Atherosclerosis 2007;194:326-333.
34. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987;84:2995-2998.
35. Qin C, Nagao T, Grosheva I, Maxfield FR, Pierini LM. Elevated plasma membrane cholesterol content alters macrophage signaling and function. Arterioscler Thromb Vasc Biol 2006;26:372-378.
36. Nagao T, Qin C, Grosheva I, Maxfield FR, Pierini LM. Elevated cholesterol levels in the plasma membranes of macrophages inhibit migration by disrupting RhoA regulation. Arterioscler Thromb Vasc Biol 2007;27:1596-1602.
37. Locher R, Brandes RP, Vetter W, Barton M. Native LDL induces proliferation of human vascular smooth muscle cells via redox-mediated activation of ERK 1/2 mitogen-activated protein kinases. Hypertension 2002;39:645-650.
38. Brown MS, Goldstein JL. Familial hypercholesterolemia: A genetic defect in the low-density lipoprotein receptor. N Engl J Med 1976;294:1386-1390.